Academic Journal

The Efficiency of Serum Biomarkers in Predicting the Clinical Outcome of Patients with Mesenteric Ischemia during Follow-Up: A Systematic Review.

التفاصيل البيبلوغرافية
العنوان: The Efficiency of Serum Biomarkers in Predicting the Clinical Outcome of Patients with Mesenteric Ischemia during Follow-Up: A Systematic Review.
المؤلفون: Mihaileanu, Florin Vasile, Popa, Stefan Lucian, Grad, Simona, Dumitrascu, Dinu Iuliu, Ismaiel, Abdulrahman, Rus, Eliza, Brata, Vlad Dumitru, Padureanu, Alexandru Marius, Dita, Miruna Oana, Turtoi, Daria Claudia, Duse, Traian Adrian, Badulescu, Andrei Vlad, Bottalico, Paolo, Chiarioni, Giuseppe, Pop, Cristina, Mogosan, Cristina, Barsan, Maria, Gherman, Claudia Diana, Stancu, Bogdan, David, Liliana
المصدر: Diagnostics (2075-4418); Apr2024, Vol. 14 Issue 7, p670, 17p
مصطلحات موضوعية: MESENTERIC ischemia, TREATMENT effectiveness, BIOMARKERS, SYMPTOMS
مستخلص: The initial clinical manifestation of acute mesenteric ischemia poses a diagnostic challenge, often leading to delays in identification and subsequent surgical intervention, contributing to adverse outcomes. Serum biomarkers, offering insights into the underlying pathophysiology, hold promise as prognostic indicators for acute mesenteric ischemia. This systematic review comprehensively explores the role of blood biomarkers in predicting clinical outcomes during follow-up for patients with mesenteric ischemia. A thorough literature search across the PubMed, Cochrane Library, and EMBASE databases yielded 33 relevant publications investigating the efficacy of serum biomarkers in predicting outcomes for mesenteric ischemia. Numerous studies underscore the utility of blood biomarkers in swiftly and accurately differentiating between causes of mesenteric ischemia, facilitating a prompt diagnosis. Elevated levels of specific biomarkers, particularly D-dimers, consistently correlate with heightened mortality risk and poorer clinical outcomes. While certain serum indicators exhibit substantial potential in associating with mesenteric ischemia, further research through rigorous human trials is imperative to enhance their consistent predictive ability during the follow-up period. This study underscores the diagnostic and prognostic significance of specific biomarkers for mesenteric ischemia, emphasizing the necessity for standardized procedures in future investigations. [ABSTRACT FROM AUTHOR]
Copyright of Diagnostics (2075-4418) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:20754418
DOI:10.3390/diagnostics14070670